SINGAPORE, April 8 (Bernama) -- Singapore's Agency for Science, Technology and Research (A*STAR) is collaborating with Italy's Siena Biotech S.p.A. to develop new drugs and targeted antibodies which will potentially help millions of cancer and bone loss patients across the world.Two of its research units, the Experimental Therapeutics Centre (ETC) and Singapore Immunology Network (SIgN), will respectively develop the drugs and antibodies, according to the agency Thursday. Full Story
Related:
Singapore And Italy Collaborate On Osteoporosis, Cancer Research - Gov Monitor
Singapore, Italy To Develop Drug, Antibodies For Cancer, Bone Loss - Bernama.com
